Enovis (ENOV) Research & Development (2010 - 2026)

Enovis (ENOV) has reported Research & Development for 8 consecutive years, with $31.7 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Research & Development rose 3.21% year-over-year to $31.7 million in Q3 2026; TTM through Jul 2026 was $124.3 million, a 19.92% increase from a year earlier, with the FY2025 full-year figure at $120.3 million, up 31.8% from the prior year.
• Research & Development was $31.7 million for Q3 2026 at Enovis, roughly flat from $31.5 million in the prior quarter.
• Over five years, Research & Development peaked at $31.7 million in Q3 2026 and troughed at $14.7 million in Q4 2022.
• A 5-year average of $22.8 million and a median of $21.9 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slipped 3.34% in 2022 and surged 45.13% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $14.7 million in 2022, then rose by 24.41% to $18.3 million in 2023, then soared by 30.74% to $24.0 million in 2024, then jumped by 30.95% to $31.4 million in 2025, then climbed by 1.02% to $31.7 million in 2026.
• The last three Research & Development figures came in at $31.7 million (Q3 2026), $31.5 million (Q2 2026), and $31.4 million (Q4 2025), per Business Quant data.